Expression and Production: The CV_1738 protein is expressed in E. coli, which is a common host for recombinant protein production due to its well-understood genetics and efficient expression systems .
Purity and Stability: The recombinant CV_1738 protein is reported to have a purity of more than 85% as determined by SDS-PAGE. Its stability and shelf life depend on storage conditions, with a recommended storage at -20°C or -80°C for long-term preservation .
Sequence Information: The sequence of CV_1738 includes a partial protein sequence, which is crucial for understanding its structure and potential functions. The sequence provided includes several motifs and domains that could be involved in protein-protein interactions or enzymatic activities .
While specific applications of the CV_1738 protein are not detailed, recombinant proteins from C. violaceum can be valuable in biotechnological and biomedical research. For instance, C. violaceum is known for producing violacein, a compound with antimicrobial, antiviral, and anticancer properties . The study of proteins like CV_1738 could provide insights into the metabolic pathways or virulence mechanisms of C. violaceum.
| Characteristic | Description |
|---|---|
| Expression Host | Escherichia coli |
| Purity | >85% (SDS-PAGE) |
| Storage Conditions | -20°C or -80°C for long-term storage |
| Sequence Information | Partial sequence available, includes various motifs |
| Stability | Dependent on storage conditions and buffer ingredients |
| Research Area | Potential Applications |
|---|---|
| Biotechnology | Study of metabolic pathways in C. violaceum |
| Biomedicine | Investigation of virulence mechanisms or novel drug targets |
| Protein Structure and Function | Elucidation of CV_1738's role in C. violaceum |
Biorxiv: A quorum sensing-regulated type VI secretion system containing...
Cusabio: Recombinant Chromobacterium violaceum UPF0313 protein CV_1738
PubMed: Biosynthesis of Violacein, Structure and Function of l-Tryptophan...
Frontiers in Microbiology: Regulation of virulence in Chromobacterium violaceum and...
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes. We will accommodate your request whenever possible.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested. Please contact us in advance for dry ice shipping; additional fees will apply.
The tag type is determined during the production process. If you require a specific tag, please inform us; we will prioritize its development.
The UPF0313 protein CV_1738 (Uniprot No. Q7NX89) is a protein of unknown function encoded by the CV_1738 gene in Chromobacterium violaceum strain ATCC 12472. It belongs to the UPF0313 protein family, which are broadly conserved bacterial proteins whose molecular functions remain to be fully characterized. The recombinant version is typically produced in mammalian cell expression systems with high purity (>85% by SDS-PAGE) for research applications focused on structure-function analysis .
While CV_1738 is classified as a UPF (Uncharacterized Protein Family) member, it should not be confused with the eukaryotic Upf proteins (Upf1, Upf2, Upf3) that function in nonsense-mediated mRNA decay (NMD). Unlike eukaryotic Upf proteins that associate with ribosomes and regulate NMD, bacterial UPF0313 family proteins have distinct evolutionary origins and functions. Research indicates that eukaryotic Upf proteins exercise their NMD functions while bound to elongating ribosomes, with evidence particularly compelling for Upf1 . The bacterial CV_1738 UPF0313 protein likely serves different cellular functions specific to bacterial physiology.
Recombinant CV_1738 protein should be stored at -20°C/-80°C upon receipt, with aliquoting necessary for multiple use to avoid repeated freeze-thaw cycles. The shelf life is typically 6 months for liquid formulations and 12 months for lyophilized forms at -20°C/-80°C . Working aliquots can be stored at 4°C for up to one week. The stability is influenced by several factors including buffer ingredients, storage temperature, and the intrinsic stability of the protein itself . For long-term storage, adding 5-50% glycerol (final concentration) is recommended before freezing.
For optimal reconstitution:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (most manufacturers default to 50%)
Aliquot for long-term storage at -20°C/-80°C
This approach minimizes protein degradation and maintains functionality for experimental applications . Avoid repeated freeze-thaw cycles as they can significantly reduce protein activity.
Since CV_1738 is part of an uncharacterized protein family, validating its activity presents unique challenges. Researchers should consider a multi-faceted approach:
Structural integrity assessment: Using circular dichroism (CD) spectroscopy to confirm proper folding
Thermal shift assays: To evaluate protein stability
Binding partner identification: Through pull-down assays coupled with mass spectrometry
Functional complementation: Testing if the recombinant protein can restore function in CV_1738 knockout C. violaceum strains
Comparative structural analysis: With other UPF0313 family members across bacterial species
These approaches collectively provide evidence of biological activity even when specific functional assays are not established.
For uncharacterized proteins like CV_1738, a systematic approach to functional characterization includes:
| Approach | Methodology | Expected Outcome |
|---|---|---|
| Genomic context analysis | Bioinformatic analysis of neighboring genes | Potential functional associations |
| Protein-protein interaction studies | Co-immunoprecipitation followed by mass spectrometry | Identification of binding partners |
| Gene knockout | CRISPR-Cas9 or homologous recombination in C. violaceum | Phenotypic consequences |
| Transcriptomic response | RNA-seq analysis comparing wild-type and ΔCV_1738 strains | Regulatory networks affected |
| Structural determination | X-ray crystallography or cryo-EM | 3D structure revealing potential functional domains |
| Heterologous expression | Expression in model organisms (E. coli) | Effects on host physiology |
This comprehensive approach leverages multiple lines of evidence to converge on functional insights .
When designing immunoassays for CV_1738:
Epitope selection: Analyze the CV_1738 sequence for immunogenic regions that are accessible in the folded protein
Antibody development: Generate polyclonal antibodies against the full-length recombinant protein or select peptide epitopes
Validation strategy: Confirm antibody specificity using:
Western blot against recombinant protein
Immunoprecipitation followed by mass spectrometry
Competitive binding assays
Testing in CV_1738 knockout strains as negative controls
Assay optimization: Determine optimal antibody concentrations, blocking conditions, and detection methods for Western blots, ELISAs, or immunohistochemistry
Cross-reactivity assessment: Test against related UPF0313 family proteins from other bacterial species
These steps ensure reliable detection of CV_1738 in complex biological samples .
When investigating CV_1738's potential role in pathogenicity:
Expression analysis: Compare CV_1738 expression between environmental and clinical C. violaceum isolates
Infection models: Assess virulence of wild-type versus ΔCV_1738 mutants in established infection models
Host response: Analyze host immune responses to CV_1738 using recombinant protein
Secretion analysis: Determine if CV_1738 is secreted via any of C. violaceum's secretion systems, particularly the Cpi-1/1a T3SS known to be essential for virulence
Comparative genomics: Analyze presence and conservation of CV_1738 across pathogenic and non-pathogenic Chromobacterium species
Host cell interaction: Examine effects of recombinant CV_1738 on host cell processes relevant to infection
C. violaceum infections typically start with localized skin infection and can progress to fulminating septicemia with multiple abscesses in the liver, lung, spleen, and other organs . Understanding if CV_1738 contributes to this pathogenesis would be valuable.
The Chromobacterium genus has expanded significantly since 2007, with nine novel species proposed beyond C. violaceum . Comparative genomic analysis reveals:
| Chromobacterium Species | UPF0313 Protein Presence | Genome Availability | Pathogenic Potential |
|---|---|---|---|
| C. violaceum ATCC 12472 | Present (CV_1738) | Complete genome | Human and animal pathogen |
| C. subtsugae | Ortholog present | Draft genomes available | Toxic to insect larvae |
| C. aquaticum | Ortholog present | Draft genome available | Non-described |
| C. haemolyticum | Ortholog present | Draft genome available | Associated with human bacteremia |
| C. vaccinii | Ortholog present | Draft genome available | Non-pathogenic to humans |
The conservation of UPF0313 proteins across the genus suggests functional importance in Chromobacterium biology, but specific roles may vary across species inhabiting different ecological niches .
Comparative analysis with characterized bacterial proteins can provide functional insights:
Sequence homology: While CV_1738 is classified as "uncharacterized," distant homologs in other bacteria may have known functions
Domain architecture: Identification of conserved domains shared with functionally characterized proteins
Structural similarities: Proteins with similar tertiary structures often have related functions even with low sequence identity
Genomic context conservation: Similar gene neighborhoods across bacteria can suggest functional relationships
Evolutionary rate: Slowly evolving proteins typically perform essential cellular functions
These comparative approaches can generate testable hypotheses about CV_1738 function despite its current uncharacterized status .
Common technical challenges and solutions include:
| Issue | Potential Causes | Troubleshooting Approach |
|---|---|---|
| Low protein yield | Suboptimal expression conditions | Optimize temperature, IPTG concentration, and duration of induction |
| Protein insolubility | Improper folding | Try different expression tags (MBP, SUMO) or expression at lower temperatures |
| Protein aggregation | Concentration too high, buffer incompatibility | Adjust buffer conditions, add stabilizing agents like glycerol |
| Activity loss during storage | Freeze-thaw cycles, oxidation | Aliquot before freezing, add reducing agents if appropriate |
| Inconsistent experimental results | Batch-to-batch variation | Use consistent purification protocols, validate each batch |
Researchers should carefully document conditions that yield functional protein and maintain consistency across experiments .
To distinguish artifacts from true biological effects:
Include appropriate controls: Use buffer-only and irrelevant protein controls in all experiments
Perform dose-response studies: Biological effects typically show dose-dependency
Use multiple protein preparations: Confirm results across independently prepared protein batches
Employ complementary methodologies: Verify findings using orthogonal techniques
Design knockout/complementation studies: Genetic validation through knockout and rescue experiments
Consider tag effects: Test both tagged and untagged versions where possible, or different tag placements
Validate with mass spectrometry: Confirm protein identity and detect potential contaminants
For protein-protein interaction analysis of CV_1738:
Proximity-dependent biotin identification (BioID): Fusion of a biotin ligase to CV_1738 to identify proximal proteins in vivo
Thermal proteome profiling: Detect proteins with altered thermal stability when bound to CV_1738
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Map interaction interfaces by measuring solvent accessibility changes
Surface plasmon resonance (SPR): Quantify binding kinetics and affinity parameters
Isothermal titration calorimetry (ITC): Measure thermodynamic parameters of binding interactions
Crosslinking mass spectrometry (XL-MS): Identify interaction interfaces through chemical crosslinking
Native mass spectrometry: Analyze intact protein complexes under native conditions
These methods provide complementary data that together create a comprehensive interaction profile .
Emerging technologies with potential to advance understanding of UPF0313 proteins include:
AlphaFold2 and other AI-based structural prediction tools: Generate high-confidence structural models that suggest functional mechanisms
Cryo-electron microscopy: Achieve high-resolution structures without crystallization
Single-cell proteomics: Track protein dynamics in individual bacterial cells
Activity-based protein profiling: Identify substrates and interaction partners
CRISPR interference (CRISPRi): Create conditional knockdowns for essential genes
Ribosome profiling: Analyze translational dynamics and regulation
Integrative multi-omics: Combine transcriptomics, proteomics, and metabolomics data
These approaches are particularly valuable for uncharacterized protein families where traditional methods have yielded limited insights .
Characterizing CV_1738 could provide insights into:
Bacterial adaptation: Understanding how C. violaceum thrives in diverse environmental niches
Evolutionary biology: Clarifying the conservation and diversification of UPF0313 proteins across bacteria
Pathogenicity mechanisms: Potentially uncovering novel virulence factors if CV_1738 contributes to pathogenesis
Bacterial stress responses: Identifying new pathways for environmental adaptation
Host-microbe interactions: Discovering novel mechanisms of bacterial survival during host colonization
These broader implications highlight why studying uncharacterized proteins remains crucial despite technical challenges .